Ahn-Gook Pharmaceutical Co. Ltd
Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.
Ahn-Gook Pharmaceutical Co. Ltd (001540) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.086x
Based on the latest financial reports, Ahn-Gook Pharmaceutical Co. Ltd (001540) has a cash flow conversion efficiency ratio of 0.086x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.44 Billion) by net assets (₩167.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ahn-Gook Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Ahn-Gook Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ahn-Gook Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ahn-Gook Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kingcan Holdings Ltd
TW:8411
|
0.081x |
|
Trident Digital Tech Holdings Ltd American Depository Shares
NASDAQ:TDTH
|
0.658x |
|
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
|
0.012x |
|
Arrienda Rental Properties SOCIMI SA
MC:YARP
|
0.052x |
|
S Chand And Company Limited
NSE:SCHAND
|
-0.061x |
|
Seri Industrial S.p.A.
LSE:0Q98
|
N/A |
|
First Resource Bank
OTCQX:FRSB
|
N/A |
|
Iskandar Waterfront City Bhd
KLSE:1589
|
0.015x |
Annual Cash Flow Conversion Efficiency for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Ahn-Gook Pharmaceutical Co. Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩165.68 Billion | ₩4.91 Billion | 0.030x | +438.78% |
| 2023-12-31 | ₩151.67 Billion | ₩-1.33 Billion | -0.009x | -175.78% |
| 2022-12-31 | ₩154.80 Billion | ₩1.79 Billion | 0.012x | +14.00% |
| 2021-12-31 | ₩145.26 Billion | ₩1.47 Billion | 0.010x | -86.95% |
| 2020-12-31 | ₩144.10 Billion | ₩11.19 Billion | 0.078x | -47.86% |
| 2019-12-31 | ₩148.25 Billion | ₩22.08 Billion | 0.149x | +1919.68% |
| 2018-12-31 | ₩146.77 Billion | ₩-1.20 Billion | -0.008x | -106.42% |
| 2017-12-31 | ₩136.96 Billion | ₩17.46 Billion | 0.128x | +32.23% |
| 2016-12-31 | ₩130.89 Billion | ₩12.62 Billion | 0.096x | -33.85% |
| 2015-12-31 | ₩131.06 Billion | ₩19.11 Billion | 0.146x | +1287.76% |
| 2014-12-31 | ₩122.46 Billion | ₩1.29 Billion | 0.011x | -63.54% |
| 2013-12-31 | ₩126.42 Billion | ₩3.64 Billion | 0.029x | -71.39% |
| 2012-12-31 | ₩114.36 Billion | ₩11.51 Billion | 0.101x | -- |